Paul E. Szurek
Net Worth
Last updated:
What is Paul E. Szurek net worth?
The estimated net worth of Mr. Paul E. Szurek is at least $99,961,202 as of 15 Mar 2021. He owns shares worth $71,007,671 as insider, has earned $6,003,531 from insider trading and has received compensation worth at least $22,950,000 in Cencora.
What is the salary of Paul E. Szurek?
Mr. Paul E. Szurek salary is $1,530,000 per year as Pres, Chief Executive Officer & Director in Cencora.
How old is Paul E. Szurek?
Mr. Paul E. Szurek is 64 years old, born in 1961.
What stocks does Paul E. Szurek currently own?
As insider, Mr. Paul E. Szurek owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Cencora (COR) | Pres, Chief Executive Officer & Director | 242,347 | $293 | $71,007,671 |
What does Cencora do?
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Paul E. Szurek insider trading
Cencora
Mr. Paul E. Szurek has made 14 insider trades between 2010-2021, according to the Form 4 filled with the SEC. Most recently he sold 7,524 units of COR stock on 15 Mar 2021.
The largest trade he's ever made was exercising 14,788 units of COR stock on 4 Mar 2021. As of 15 Mar 2021 he still owns at least 242,347 units of COR stock.
Cencora key executives
Cencora executives and other stock owners filed with the SEC:
- Mr. Brian P. Warren (55) Senior Vice President of Devel. & Product Engineering
- Mr. Derek S. McCandless (54) Senior Vice President of Legal, Gen. Counsel & Sec.
- Mr. Jeffrey S. Finnin (62) Chief Financial Officer & Treasurer
- Mr. Paul E. Szurek (64) Pres, Chief Executive Officer & Director
- Mr. Steven J. Smith (60) Chief Revenue Officer